Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: SEC filing

Re: update another new Institutional investor..makes 3 new as of 12-31-08

posted on Feb 18, 2009 04:13AM

I think the point is that they are aware of PTSC, and hence might be inclined to buy more on + news. Opty

Share
New Message
Please login to post a reply